pe
pep-05138 v1 CC-BY-SA-4.0

POMC metabolic peptide

An early-stage peptide that acts on the body's blood-sugar and appetite control system; being studied as a possible metabolic treatment, not an approved drug.

statuscomputed targetGLP-1R length32 aa refs2
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.728
pTM0.720
avg pLDDT68.8
ranking score0.696
STRUCTURE · PEP-05138 × GLP-1R
ranking0.696
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence32 aa
15101520253032
FRWGKPVGKKRRPVKV YPNGAEDESAEAFPLE
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7276095747947693 boltz-2
ranking score 0.6960158348083496 boltz-2
structural qualityopenfold3
metricvaluenote
gpde1.213global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). POMC metabolic peptide (pep-05138, v1). PeptideModel. https://peptidemodel.com/card/pep-05138
@peptide{pep05138,
  sequence = {FRWGKPVGKKRRPVKVYPNGAEDESAEAFPLE},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 4 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use